| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Feb 25 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 58.95 | 3,562.341 | 210.00 k | 32,223.091 |
| 3 Oct 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.25 | 12,082 | 63.43 k | 12,082 |
| 1 Oct 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 47,232 | 246.55 k | 47,232 |
| 1 Oct 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.22 | 56,636 | 295.64 k | 56,636 |
| 7 Mar 24 | OTLK Outlook Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.41 | 94,441 | 38.72 k | 94,441 |
| 1 Feb 24 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 48.67 | 4,314.773 | 210.00 k | 27,341.22 |
| 31 Dec 23 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 51.31 | 706.49 | 36.25 k | 22,746.04 |
